Dr. Allen is a serial entrepreneur and executive, with experience leading organizations from inception to profitable growth to successful exit. He is a Co-Founder & Advisor at VOICEplug, providing strategic inputs and leadership coaching covering marketing, finance and legal areas.
Dr. Allen has a BS in Applied Physics from Columbia University and an MD from UCLA. During his medical training, he developed one of the first web-based clinical decision support systems to guide doctors to make the right patient care decisions. After clinical trials, Dr. Allen founded Corticon to bring this new technology to market. Under Dr. Allen’s leadership as CEO, Corticon became one of the leading commercial rules engine software products. When Corticon was acquired by Progress (NASD: PRGS), Dr. Allen took roles as Chief Technologist and then General Manager.
In 2017, Dr. Allen co-founded the biopharma company Elevian. Elevian are developing drugs that target aging, with the potential to treat and prevent multiple age-related diseases . An active member of YPO since 2009, Dr. Allen also serves on the board of YPO SF Gold and RIZE Holdings.
LinkedIn: Dr. Mark Allen